BII
NKTR icon

Bainco International Investors’s Nektar Therapeutics NKTR Stock Holding History

Bainco International Investors’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$3K Buy
+9
New +$2.33K ﹤0.01% 210
2020
Q2 		– Sell
-9
Closed -$2K – 191
2020
Q1 		$2K Buy
+9
New +$2.78K ﹤0.01% 253

Other funds holding NKTR

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Bainco International Investors's NKTR Position: Q4 2020 in Review

Bainco International Investors opened a new position in Nektar Therapeutics (NKTR) in Q4 2020: 9 shares worth $3K. The stake represents ﹤0.01% of the portfolio and ranks #210 among its holdings. This is a return to the name: Bainco International Investors previously reported a position in NKTR as recently as Q1 2020.

Bainco International Investors first reported a position in NKTR in Q1 2020 and has held it in 2 quarters since. 246 funds tracked by Wall St. Rank hold NKTR as of Q4 2020.

  • Bainco International Investors held 9 shares of Nektar Therapeutics worth $3K as of Q4 2020.
  • Nektar Therapeutics was a new Bainco International Investors position in Q4 2020.
  • Nektar Therapeutics made up ﹤0.01% of Bainco International Investors's portfolio in Q4 2020, its #210 holding.
  • Bainco International Investors first reported a position in Nektar Therapeutics in Q1 2020 and has held it in 2 quarters since.
  • 246 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q4 2020.

Based on Bainco International Investors's 13F filing for Q4 2020, filed 12 Jan 2021.